Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
150,858,761
-
Total 13F shares
-
89,252,994
-
Share change
-
+13,376,987
-
Total reported value
-
$2,277,667,387
-
Put/Call ratio
-
51%
-
Price per share
-
$25.52
-
Number of holders
-
156
-
Value change
-
+$376,305,703
-
Number of buys
-
85
-
Number of sells
-
71
Institutional Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q1 2024
As of 31 Mar 2024,
Avidity Biosciences, Inc. - Common Stock (RNA) was held by
156 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,252,994 shares.
The largest 10 holders included
FMR LLC, RTW INVESTMENTS, LP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Avoro Capital Advisors LLC, COWEN AND COMPANY, LLC, VANGUARD GROUP INC, STATE STREET CORP, RA CAPITAL MANAGEMENT, L.P., and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
156
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.